Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA approves filgrastim for myelosuppression in acute radiation injury

April 23, 2015

Tamoxifen found to inhibit the effects of amphetamine

April 21, 2015

Northeastern University patents CB1 receptor modulators

March 12, 2015

Substance abuse candidate GS-6637 well tolerated in healthy volunteers

March 10, 2015

Reversible change in enzyme's substrate specificity accelerates elimination of toxic acetaldehyde

Feb. 27, 2015

Cerecor acquires kappa opioid receptor antagonist from Eli Lilly

Feb. 23, 2015

Pluristem Therapeutics reports results for PLX-R18 in animal model of ARS

Feb. 18, 2015

Elite Pharmaceuticals plans phase III trial of abuse-deterrent opioid

Feb. 18, 2015

FDA grants fast track designation to intranasal naloxone treatment

Feb. 18, 2015

Scientists at Instituto Italiano di Tecnologia disclose FAAH inhibitors

Feb. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...